Showing results (181-190 of 521) with videos related to

Sort By:
Pageof 53
European Journal of Heart Failure|May 11, 2024
Sacubitril/valsartan and cardiovascular biomarkers among patients with recent COVID-19 infection: The PARACOR-19 randomized clinical trialStephen J Greene, RaKavius Chambers, Joseph B Lerman, et al.
Current Heart Failure Reports|April 15, 2024
Putting More Weight on Obesity Trials in Heart FailureJosephine Harrington, Naveed Sattar, G Michael Felker, et al.
Journal of Cardiac Failure|April 28, 2022
Quantitative Blood Volume Analysis and Hemodynamic Measures of Vascular Compliance in Patients With Worsening Heart FailureVishal N Rao, Jennifer Andrews, Willard N Applefeld, et al.
Circulation. Heart Failure|November 12, 2020
Effects of Omecamtiv Mecarbil on Symptoms and Health-Related Quality of Life in Patients With Chronic Heart Failure: Results From the COSMIC-HF StudyG Michael Felker, Scott D Solomon, John J V McMurray, et al.
Kidney International|November 6, 2009
A secondary analysis of the CHOIR trial shows that comorbid conditions differentially affect outcomes during anemia treatmentLynda A Szczech, Huiman X Barnhart, Shelly Sapp, et al.
European Journal of Heart Failure|November 5, 2016
Biomarker-based risk prediction in the communityOmar F AbouEzzeddine, Paul M McKie, Christopher G Scott, et al.
American Journal of Physiology. Renal Physiology|April 8, 2004
Pathophysiology of functional mutations of the thiazide-sensitive Na-Cl cotransporter in Gitelman diseaseErnesto Sabath, Patricia Meade, Jennifer Berkman, et al.
Biochemical and Biophysical Research Communications|November 27, 2015
Degradation by Cullin 3 and effect on WNK kinases suggest a role of KLHL2 in the pathogenesis of Familial Hyperkalemic HypertensionChong Zhang, Nicholas P Meermeier, Andrew S Terker, et al.
Pageof 53